Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study74

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study27

Views

Views
December 20250
January 20260
February 20260
March 20263
April 20268
May 20264
June 202612
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Netherlands5
Australia1
Spain1
Finland1
Kenya1
Mexico1
 

Top cities views

Views
Groningen5
Piscataway2
Council Bluffs2
Ciudad Juárez1
Dallas1
Harrisburg1
Helsinki1
Largo1
Los Angeles1
Madrid1